Status:
COMPLETED
Vapocoolant Spray Effectiveness On Arterial Puncture Pain: Randomized Double Blind Placebo-Controlled Trial
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Puncture Site Pain
Eligibility:
All Genders
14+ years
Phase:
NA
Brief Summary
This study was aimed to compare pain levels from arterial blood gas (ABG) sampling performed with vapocoolant spray in comparison to placebo.
Detailed Description
Previous studies of vapocoolant sprays for reducing pain were mainly on venopuncture with inconsistent results. There was only one prospective open labeled controlled study on arterial blood gas sampl...
Eligibility Criteria
Inclusion
- age of 14 years or older,
- needs ABG as a part of their diagnosis
Exclusion
- history of analgesic medication used within 24 hours of enrollment,
- any sign of decreased consciousness,
- history of skin hypersensitivity,
- inability to report a pain score,
- history of a known neurological problem that changes pain perception,
- history of cold related reactions (e.g. Raynaud's phenomenon, cold urticaria),
- abnormal Allen's test
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01860248
Start Date
May 1 2012
End Date
June 1 2013
Last Update
July 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imam Khomeini hospital complex
Tehran, Tehran Province, Iran